Dilantin and Electrocardiogram st segment depression - a phase IV clinical study of FDA data

Summary:

Electrocardiogram st segment depression is reported as a side effect among people who take Dilantin (phenytoin sodium), especially for people who are female, 60+ old, also take Propulsid, and have Pain.

The phase IV clinical study analyzes which people have Electrocardiogram st segment depression when taking Dilantin. It is created by eHealthMe based on reports of 19,857 people who have side effects when taking Dilantin from the FDA, and is updated regularly.

What is Dilantin?

Dilantin has active ingredients of phenytoin sodium. It is often used in epilepsy. eHealthMe is studying from 20,858 Dilantin users. Check the latest studies of Dilantin.

What is Electrocardiogram st segment depression?

Electrocardiogram st segment depression is found to be associated with 455 drugs and 677 conditions by eHealthMe. Check the latest studies of Electrocardiogram st segment depression.



On Jun, 17, 2026

19,857 people reported to have side effects when taking Dilantin.
Among them, 11 people (0.06%) have Electrocardiogram st segment depression.

Could Dilantin cause Electrocardiogram st segment depression?

Among these 11 people:

What is the gender of people who have Electrocardiogram st segment depression when taking Dilantin? *

  • female: 54.55 %
  • male: 45.45 %

What is the age of people who have Electrocardiogram st segment depression when taking Dilantin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 14.29 %
  • 40-49: 14.29 %
  • 50-59: 14.29 %
  • 60+: 57.14 %

What are other drugs people take besides Dilantin? *

  1. Norvasc: 7 people, 63.64%
  2. Propulsid: 7 people, 63.64%
  3. Lasix: 5 people, 45.45%
  4. Effexor: 5 people, 45.45%
  5. Coumadin: 5 people, 45.45%
  6. Allegra: 4 people, 36.36%
  7. Reglan: 4 people, 36.36%
  8. Lorcet-Hd: 4 people, 36.36%
  9. Flexeril: 4 people, 36.36%
  10. Meclizine: 4 people, 36.36%

What are other side effects people have besides Electrocardiogram st segment depression? *

  1. Stress And Anxiety: 6 people, 54.55%
  2. Joint Pain: 5 people, 45.45%
  3. Depression: 5 people, 45.45%
  4. Dizziness: 5 people, 45.45%
  5. Dyspnea (difficult or laboured breathing): 5 people, 45.45%
  6. Pain: 5 people, 45.45%
  7. Head Injury: 5 people, 45.45%
  8. Fatigue (feeling of tiredness): 5 people, 45.45%
  9. Gait Disturbance: 5 people, 45.45%
  10. Weakness: 4 people, 36.36%

What are the existing conditions these people have? *

  1. Pain: 4 people, 36.36%
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 9.09%
  3. Cardiac Disorder: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Dilantin and have Electrocardiogram st segment depression?

- Check whether Electrocardiogram st segment depression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dilantin:

Electrocardiogram st segment depression treatments and more:

How severe was Electrocardiogram st segment depression and when was it recovered:

Expand to all the drugs that have ingredients of phenytoin sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dilantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Electrocardiogram st segment depression:

Browse all the conditions that are associated with Electrocardiogram st segment depression:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on phenytoin sodium (the active ingredients of Dilantin) and Dilantin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: